insights_auto
Why is GUD down 3,01%?
Dive Deeperchevron_right
GUD:TSE
Knight Therapeutics Inc
CAD 10,32
arrow_downward
-3,01%(-0,32) 1D
2 Okt., 16:00:00 GMT-4 · CAD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GUD...
Open
CAD 10,67
High
CAD 10,80
Low
CAD 10,31
Mkt. cap
1,01 mjd
Avg. vol.
80,48 k
Volume
63,81 k
P/E ratio
68,81
52-wk high
CAD 10,80
52-wk low
CAD 5,66
EPS
CAD 0,15
Beta
-0,07
Shares outstanding
98,23 m
No. of employees
830
Open
CAD 10,67
High
CAD 10,80
Low
CAD 10,31
Mkt. cap
1,01 mjd
Avg. vol.
80,48 k
Volume
63,81 k
P/E ratio
68,81
52-wk high
CAD 10,80
52-wk low
CAD 5,66
EPS
CAD 0,15
Beta
-0,07
Shares outstanding
98,23 m
No. of employees
830
News stories
From web sources and news partners
Korea JoongAng Daily
·
20 minute gelede
SK hynix shareholders move to block Solidigm Nasdaq listing over dilution fears
Moomoo
·
1 uur gelede
The Next Generational AI Monopoly: Why Rezolve AI ($RZLV) is a Screaming Buy Before a 10x Repricing
marketscreener.com
·
1 uur gelede
Gold gains as October Fed rate hike prospects fade
Profile
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
About Knight Therapeutics Inc
CEO-
Employees830
Founded2014
HeadquartersMontreal, Quebec, Kanada
SectorPharmaceutical industry
Websiteknighttx.com